Are Gastrointestinal Symptoms Specific for COVID-19 Infection? A Prospective Case-Control Study from the United States
Thuluvath, Paul J.
MetadataShow full item record
Summary in foreign language
The reported prevalence of gastrointestinal (GI) symptoms, including anorexia, diarrhea, nausea, vomiting, and abdominal pain, in SARS-2-CoV infection has been highly variable ranging from 5-61%.1-7 Although the Centers for Disease Control (CDC) guidelines for testing for COVID-19 include vomiting and diarrhea, all studies to date have been retrospective and none have evaluated the prevalence of GI symptoms among patients tested negative for COVID19. In this prospective case-control study, we compared the prevalence of GI symptoms between those who tested positive and negative for COVID-19 and determined the association between GI symptoms and COVID-19 diagnosis or outcomes.
Link to resourcehttps://www.sciencedirect.com/science/article/pii/S0016508520306648
Estadísticas Google Analytics
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.